American College of Clinical Pharmacy
      Search      Cart
         

PSAP in JACCP - Part I: Interactive Case: Hyperlipidemia Management for Special Populations and Part II: Interactive Case: Cardiovascular Diseases in Pregnancy - 2022 September


Member Price:
$29.95
Nonmember Price:
$29.95

Faculty Information

PSAP in JACCP features are developed from activities presented as part of the Pharmacotherapy Self-Assessment Program (PSAP).

Part I: Interactive Case: Hyperlipidemia Management for Special Populations

This feature was developed from an interactive case presented in PSAP 2022 Book 1 (Cardiology).

  • Interactive Case: Click here to access the interactive case.
Part II: Interactive Case: Cardiovascular Diseases in Pregnancy

This feature was developed from an interactive case presented in PSAP 2022 Book 1 (Cardiology).

  • Interactive case: Click here to access the interactive case.

Author - Reviewer Information

Part I: Interactive Case: Hyperlipidemia Management for Special Populations

Authors: Glenn Herrington, Pharm.D., AACC, BCCP, BCPS, CDCES; and Daniel M. Riche, Pharm.D., FCCP, CLS, ASH-CHC
Reviewed by: Elisabeth M. Wang, Pharm.D., BCCP; Jessica Bente, Pharm.D., BCPS, BCGP; and Eman Elsayed Younis, Pharm.D., BCPS-AQ Cardiology

Part II: Interactive Case: Cardiovascular Diseases in Pregnancy

Author: Lindsey Federle, Pharm.D., BCCP, BCPS
Reviewed by: Jessie Dunne, Pharm.D., BCPS, BCCP; and Leslie Wooten, Pharm.D., BCPS

Target Audience and Learning Objectives

Part I: Interactive Case: Hyperlipidemia Management for Special Populations

Target audience for this application-based activity:
Pharmacotherapy specialists and advanced level clinical pharmacists encountering diverse cardiovascular patient populations.

Learning Objectives

  1. Evaluate cardiovascular risk and complications to apply pharmacologic management strategies for hyperlipidemia in older adult patients.
  2. Apply pharmacologic management strategies for hyperlipidemia in patients of various racial/ethnic backgrounds.
  3. Apply pharmacologic management strategies for hyperlipidemia in patients with HIV infection.
  4. Apply pharmacologic management strategies for familial hyperlipidemia.
Part II: Interactive Case: Cardiovascular Diseases in Pregnancy

Target audience for this application-based activity:
Pharmacotherapy specialists and advanced level clinical pharmacists encountering diverse cardiovascular patient populations.

Learning Objectives

  1. Evaluate patient risk factors for cardiovascular complications during pregnancy and stratify according to the modified WHO pregnancy risk classes.
  2. Distinguish the physiologic and pharmacokinetic changes that occur in pregnancy.
  3. Assess hypertensive disorders of pregnancy and devise treatment plans throughout pregnancy.
  4. Develop an appropriate medical regimen for peripartum cardiomyopathy.
  5. Design safe and effective anticoagulant regimens during pregnancy.
  6. Develop pharmacotherapy to manage acute arrhythmia in the pregnant patient.

Disclosure of Potential Conflicts of Interest

Part I: Interactive Case: Hyperlipidemia Management for Special Populations

Daniel M. Riche: Consultancies (Novo Nordisk; Merck; AstraZeneca); Royalties (McGraw-Hill)
Jessica Bente: Grants (New Jersey Society of Health-System Pharmacists)
Nothing to disclose: Glenn Herrington, Elisabeth M. Wang, Eman Elsayed Younis

Part II: Interactive Case: Cardiovascular Diseases in Pregnancy

Jessie Dunne: Consultancies (Pulmonary Hypertension Association)
Nothing to disclose: Lindsey Federle, Leslie Wooten

Continuing Pharmacy Education and Recertification Instructions

Available CPE/Recertification credits: Anyone who purchases, successfully completes and passes the required posttests for this feature can earn up to 3.0 contact hours of CPE/Recertification credit.

Part I: Interactive Case: Hyperlipidemia Management for Special Populations

Universal Activity Number: 0217-0000-22-086-H01-P
1.5 CPE contact hours
Application-Based Activity

Part II: Interactive Case: Cardiovascular Diseases in Pregnancy

Universal Activity Number: 0217-0000-22-087-H01-P
1.5 CPE contact hours
Application-Based Activity

Release date: September 8, 2022
BCPS posttest submission deadline: 11:59 p.m. (Central) on March 8, 2023.
ACPE posttest submission deadline: 11:59 p.m. (Central) on September 8, 2025.

TO EARN CPE/RECERTIFICATION CREDIT FROM THIS FEATURE
Posttest access: Purchase the required posttests (see below); then go to www.accp.com and sign in with your e-mail address and password. PSAP in JACCP features are listed under My Products on your My Account page.
Technical support is available from 8 a.m. to 5 p.m. (Central) weekdays by e-mail at [email protected].

Release Date: September 08, 2022
BCPS Deadline: March 08, 2023
ACPE Deadline: September 08, 2025

Format: Online Test

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American College of Clinical Pharmacy is approved by BPS as a provider for the recertification of BCPS.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.